Cardio Diagnostics’ AI-driven coronary heart disease (CHD) tests have taken another promising step in their evolution. Cardio Diagnostics CDIO, an artificial…
CHICAGO - Cardio Diagnostics Holdings, Inc. , an AI-driven precision cardiovascular medicine company, today announced that the American Medical Association has assigned a dedicated Current.
This is the second CPT PLA code the American Medical Association granted for the Company’s AI-powered coronary heart disease tests. This significant milestone enables the acceleration of.
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares enjoy a growth spurt Tuesday, as the AI-driven precision cardiovascular medicine company, today announced that the American Medical Association (AMA) has assigned a dedicated Current Procedural .
Obtaining a CPT PLA code marks a key milestone in securing reimbursement from federal and private payers for, and expanding access to the innovative PrecisionCHD test powered by AI and epigenetics
.